JABFM
HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of the American Board of Family Medicine 21 (4): 261-268 (2008)
DOI: 10.3122/jabfm.2008.04.070169
© 2008 American Board of Family Medicine
This Article
Right arrow Full Text Freely available
Right arrow Full Text (PDF) Freely available
Right arrow Rapid Responses: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Rapid Responses are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Xu, J.
Right arrow Articles by Sobel, J. D.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Xu, J.
Right arrow Articles by Sobel, J. D.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Original Research

Effect of Antibiotics on Vulvovaginal Candidiasis: A MetroNet Study

Jinping Xu, MD, MS, Kendra Schwartz, MD, MSPH, Monina Bartoces, PhD, Joseph Monsur, BS, Richard K. Severson, PhD and Jack D. Sobel, MD

Department of Family Medicine and Public Health Sciences, Division of Practice-Based Research (JX, KS, MB, JM, RKS), Wayne State University School of Medicine, Detroit, Michigan
Department of Internal Medicine, Division of Infectious Diseases (JDS), Wayne State University School of Medicine, Detroit, Michigan

Correspondence: Corresponding author: Jinping Xu, MD, MS, Department of Family Medicine and Public Health Sciences, School of Medicine, Wayne State University, 101 E. Alexandrine, 2nd Floor, Detroit, MI 48021 (E-mail: jxu{at}med.wayne.edu)

Purpose: Vulvovaginal candidiasis (VVC) is believed common after systemic antibiotic therapy, yet few studies demonstrate this association. In this pilot study, we evaluate the effect of short-course oral antibiotic use on VVC.

Methods: Nonpregnant women aged 18 to 64 years who required ≥3 days oral antibiotics for nongynecological diseases were recruited from a family medicine office. Age-matched (±5 years) women seen in the same clinic for noninfectious problems were recruited as controls. The main outcomes are incidence of symptomatic VVC and prevalence of positive vaginal Candida culture 4 to 6 weeks after antibiotics.

Results: Eighty (44 in antibiotic group) women were recruited; 14 of 79 (95% CI, 0.11–0.28) had asymptomatic vaginal Candida cultures positive at baseline. During follow-up, 10 of 27 (95% CI, 0.22–0.56) women in antibiotic group were Candida culture positive. In contrast, 3 of 27 (95% CI, 0.04–0.28) women in the control group were Candida culture positive (relative risk, 3.33; P = .03). Meanwhile, 6 of 27 (95% CI, 0.11–0.41) women in antibiotic group developed symptomatic VVC whereas none (95% CI, 0–0.12) of the women in the control group developed vaginal symptoms (relative risk, {infty}; P = .02). Baseline Candida culture did not predict subsequent symptomatic VVC after antibiotics.

Conclusion: In this pilot study, the use of short courses of oral antibiotics seems to increase prevalence of asymptomatic vaginal Candida colonization and incidence of symptomatic VVC. Larger cohort studies are needed to confirm these findings.



Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J Antimicrob ChemotherHome page
N. Adriaenssens, S. Coenen, A. Muller, V. Vankerckhoven, H. Goossens, and on behalf of the ESAC Project Group
European Surveillance of Antimicrobial Consumption (ESAC): outpatient systemic antimycotic and antifungal use in Europe
J. Antimicrob. Chemother., April 1, 2010; 65(4): 769 - 774.
[Abstract] [Full Text] [PDF]


Home page
J Am Board Fam MedHome page
S. Tandon
Re: Effect of Antibiotics on Vulvovaginal Candidiasis: A MetroNet Study
J Am Board Fam Med, March 1, 2009; 22(2): 223 - 223.
[Full Text] [PDF]


Home page
J Am Board Fam MedHome page
J. Xu
Response: Re: Effect of Antibiotics on Vulvovaginal Candidiasis: A Metronet Study
J Am Board Fam Med, March 1, 2009; 22(2): 223 - 223.
[Full Text] [PDF]


Home page
J Am Board Fam MedHome page
M. A. Bowman, A. V. Neale, and P. Lupo
Third Journal of the American Board of Family Medicine Practice-based Research Theme Issue
J Am Board Fam Med, July 1, 2008; 21(4): 255 - 257.
[Full Text] [PDF]




HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by the American Board of Family Medicine.